FDA label
What is Briviact used for?
Briviact contains brivaracetam. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Briviact?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Briviact, tablet, film coated
Indications and Usage, quoted from the label by UCB, Inc. (NDA205836). Cross-references to other label sections are left out.
BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Source: DailyMed label, set id 3cf2f439-0e97-443e-8e33-25ecef616f6c, version 27, effective August 20, 2026. NDC 50474-370, one of 5 listings for this product.
Questions
What is Briviact used for?
The FDA label says: “BRIVIACT is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Briviact
- Is Briviact a controlled substance?Schedule V
- Generic for BriviactFDA Orange Book
- What is Brivaracetam used for?FDA label uses
- Is Brivaracetam a controlled substance?Schedule V
- Briviact Medicare Part D coverageBy plan and state
- NDC 50474-370Briviact NDC record
- NDC 50474-470Briviact NDC record
- NDC 50474-570Briviact NDC record
- Schedule V drugs listDEA schedule